DALTON HENDERSON: Open Payments
NPI 1841914439 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,215 in 138 payments from 23 companies in 2025. Trend: 2023 $1,468 · 2024 $2,117 · 2025 $2,215
Food & beverage: $2,215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $379 |
| Novo Nordisk Inc | 23 | $295 |
| Lilly USA, LLC | 14 | $282 |
| AstraZeneca Pharmaceuticals LP | 9 | $238 |
| Axsome Therapeutics, Inc. | 10 | $151 |
| PFIZER INC. | 10 | $145 |
| Eisai Inc. | 5 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Phathom Pharmaceuticals, Inc. | 8 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
Products named: MOUNJARO, UBRELVY, AIRSUPRA, Leqembi, Wegovy, QULIPTA, Auvelity, LEQVIO.
Industry payments across KY — which companies pay providers there.
